uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)
uniQure (QURE) posted quarterly Non-Current Deffered Revenue of $22.4 million for Q3 2020, down 6.15% year-over-year from $23.9 million in Q4 2019, and down 2.76% quarter-over-quarter from $23.0 million in Q2 2020.
Analysis
uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends
uniQure's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $22.4 million for Q3 2020.
- In Q3 2020, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million; the TTM figure through Sep 2020 stood at $22.4 million (down 6.15% YoY), while the FY2019 annual figure was $23.1 million, down 19.83% from the prior year.
- Non-Current Deffered Revenue for Q3 2020 stood at $22.4 million, down from $23.0 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $78.7 million in Q2 2017, with the low at $22.4 million in Q3 2020.
- The 5-year median for Non-Current Deffered Revenue is $29.4 million (2018), against an average of $41.4 million.
- The sharpest annual moves came in 2018 and 2020: Non-Current Deffered Revenue tumbled 58.27% in 2018, then slipped 6.15% in 2020.
- uniQure's Non-Current Deffered Revenue stood at $75.6 million in 2016, then slipped by 10.85% to $67.4 million in 2017, then tumbled by 57.18% to $28.9 million in 2018, then decreased by 19.83% to $23.1 million in 2019, then decreased by 3.13% to $22.4 million in 2020.
- Business Quant data shows QURE's Non-Current Deffered Revenue at $22.4 million in Q3 2020, $23.0 million in Q2 2020, and $23.7 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 147.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 22.41 Mn |
| Jun 30, 2020 | 23.05 Mn |
| Mar 31, 2020 | 23.71 Mn |
| Dec 31, 2019 | 23.14 Mn |
| Sep 30, 2019 | 23.88 Mn |
| Jun 30, 2019 | 26.35 Mn |
| Mar 31, 2019 | 27.47 Mn |
| Dec 31, 2018 | 28.86 Mn |
| Sep 30, 2018 | 29.85 Mn |
| Jun 30, 2018 | 32.85 Mn |
| Mar 31, 2018 | 36.15 Mn |
| Dec 31, 2017 | 67.41 Mn |
| Sep 30, 2017 | 67.86 Mn |
| Jun 30, 2017 | 78.73 Mn |
| Mar 31, 2017 | 75.40 Mn |
| Dec 31, 2016 | 75.61 Mn |
| Dec 31, 2015 | 83.45 Mn |